Patient stem cells help identify common problem in ALS

A recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis -- Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder, new stem cell research has shown. The researchers are now designing an initial clinical trial testing the safety of the treatment in ALS patients.